Delivery Order SPE2DB20D1100-SPE2DB25FB8Z0
- Not listed
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $25,361.92 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $9,111.37. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,401.81 on July 22, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,665.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The award, issued on June 27, 2025, with a completion date of June 30, 2025, represents a non-set-aside competitive procurement. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,516.23 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Januvia 100 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,610.79 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB8Z0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,118.08 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was issued on April 23, 2025, with an ultimate completion date of April 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare procurement. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains through its DLA contracts, including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialty medical supplies. This Januvia order supports the Defense Health Agency and other federal healthcare systems' medication supply requirements. The contract received no set-aside designation and was awarded through open competition, demonstrating AmerisourceBergen's capability to meet federal procurement standards alongside other potential vendors in the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/23/25 |